Lifecore Biomedical downgraded by Stephens with a new price target

3/20/23 7:49:42 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Stephens downgraded Lifecore Biomedical from Overweight to Equal-Weight and set a new price target of $2.00 from $11.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$LFCR

Date	Price Target	Rating	Analyst
5/21/2025		Outperform	William Blair
9/5/2024	$8.00	Buy	Craig Hallum
8/28/2024		Outperform → Mkt Perform	Barrington Research
3/20/2023	$11.00 → $2.00	Overweight → Equal-Weight	Stephens